Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 54,184 | 0 | 13,418,000 | 11,724,000 | 9,284,000 |
| Cost of Goods | N/A | N/A | 1,744,000 | 1,571,000 | 1,181,000 |
| Gross Profit | 54,184 | N/A | 11,674,000 | 10,153,000 | 8,103,000 |
| Operating Expenses | 125,782 | 0 | 6,605,000 | 5,914,000 | 4,897,000 |
| Operating Income | -71,598 | N/A | 5,069,000 | 4,239,000 | 3,206,000 |
| Interest Expense | 2,421 | 0 | 82,000 | 76,000 | 74,000 |
| Other Income | -45,816 | 0 | 444,000 | 263,000 | 271,000 |
| Pre-tax Income | -119,835 | 0 | 5,431,000 | 4,426,000 | 3,403,000 |
| Income Tax | 22 | N/A | 2,004,000 | 1,657,000 | 1,290,000 |
| Net Income Continuous | -119,857 | N/A | 3,427,000 | 2,769,000 | 2,113,000 |
| Minority Interests | -530 | N/A | N/A | N/A | N/A |
| Net Income | $-119,327 | $N/A | $3,427,000 | $2,769,000 | $2,113,000 |
| EPS Basic Total Ops | -4.00 | N/A | 3.25 | 2.63 | 2.01 |
| EPS Basic Continuous Ops | -4.17 | N/A | 3.25 | 2.63 | 2.01 |
| EPS Diluted Total Ops | -4.00 | N/A | 3.21 | 2.59 | 1.97 |
| EPS Diluted Continuous Ops | -4.17 | N/A | 3.21 | 2.59 | 1.97 |
| EBITDA(a) | $-60,843 | $N/A | $5,661,000 | $4,731,000 | $3,613,000 |